BMY: Summary for BRISTOL-MYERS SQUIBB - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 1:41am EST - Canadian Markets open in 7 hours and 49 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Bristol-Myers Squibb Company (BMY)

On Feb 9: 24.25 USD

0.29 (1.21%)

MORE ON BMY

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BRISTOL-MYERS SQUIBB (NYSE:BMY) Delayed quote data

After Hours: 24.25 0.00 (0.00%) as of 4:31pm EST on 02/09/10

Last Trade:	24.25 USD
Trade Time:	Feb 9
Change:	0.29 (1.21%)
Prev Close:	23.96
Open:	24.10
Bid:	N/A
Ask:	N/A
1y Target Est:	25.22

Day's Range:	23.90 - 24.41
52wk Range:	17.23 - 26.62
Volume:	9,906,506
Avg Vol (3m):	26,002,100
Market Cap:	48.04B
P/E (ttm):	4.51
EPS (ttm):	5.38
Div & Yield:	1.25 (5.22%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add BMY to Portfolio

Download Data

HEADLINES

•	Pfizer Off 2% As 2010 Targets Miss; Posts Revised 2012 Targets
	at Barrons.com (Tue 8:20pm)

•	Researchers find sex-specific lung cancer genes
	at Reuters (Tue 7:34pm)

•	How Much Should Cancer Drugs Cost?
	at The Wall Street Journal Online (Tue 4:05pm)

•	Make Thousands From Millions
	at Motley Fool (Tue 1:20pm)

•	UPDATE - U.S. FDA staff questions small ChemGenex study
	at Reuters (Mon, Feb 8)

•	UK says Novartis, Bristol cancer drugs too costly
	at Reuters (Mon, Feb 8)

•	Monday Options Recap: Volatility Eases
	at Seeking Alpha (Mon, Feb 8)

•	Correction is Healthy - and a Buying Opportunity: Strategist
	at CNBC (Mon, Feb 8)

•	AMRI reports $19M net loss in 4Q
	at bizjournals.com (Mon, Feb 8)

•	UPDATE - U.S. FDA staff questions small ChemGenex study
	at Reuters (Mon, Feb 8)

•	How Big Pharma Got in This Fix
	at Seeking Alpha (Sun, Feb 7)

•	Bristol-Myers Squibb to freeze salaries in 2010
	AP (Fri, Feb 5)

•	Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
	at The New York Times (Fri, Feb 5)

•	Why Pharma's Patent Cliff Is Good News for Pharmacies
	at The Wall Street Journal Online (Fri, Feb 5)

•	[$$] Cost Cutting Boosts Profits
	at The Wall Street Journal Online (Thu, Feb 4)

More Headlines for BMY...

ANALYST

EPS Est (next year) (Dec-10) :	2.21
EPS Est (in 2 years) (Dec-11) :	2.45
Avg Rec (current)*:	2.7
PEG Ratio:	4.65

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Bristol-Myers Squibb Company, a global biopharmaceutical company, engages in discovering, developing, and delivering medicines that help patients prevail over serious diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•